SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009274
Filing Date
2023-05-11
Accepted
2023-05-11 08:23:34
Documents
68
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mgtx-20230331x10q.htm   iXBRL 10-Q 1759419
2 EX-31.1 mgtx-20230331xex31d1.htm EX-31.1 11369
3 EX-31.2 mgtx-20230331xex31d2.htm EX-31.2 11319
4 EX-32.1 mgtx-20230331xex32d1.htm EX-32.1 6760
5 EX-32.2 mgtx-20230331xex32d2.htm EX-32.2 6768
  Complete submission text file 0001558370-23-009274.txt   6793299

Data Files

Seq Description Document Type Size
6 EX-101.SCH mgtx-20230331.xsd EX-101.SCH 50846
7 EX-101.CAL mgtx-20230331_cal.xml EX-101.CAL 48381
8 EX-101.DEF mgtx-20230331_def.xml EX-101.DEF 189483
9 EX-101.LAB mgtx-20230331_lab.xml EX-101.LAB 368827
10 EX-101.PRE mgtx-20230331_pre.xml EX-101.PRE 327957
62 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20230331x10q_htm.xml XML 1096978
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38520 | Film No.: 23908990
SIC: 2836 Biological Products, (No Diagnostic Substances)